TRACON(TCON) - 2023 Q4 - Earnings Call Transcript

Company Participants Soumit Roy - Jones Research Steve Bersey - H.C. Wainwright During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, financing opportunities, our development plan and strategies, potential cost savings and other benefits deliverable through our product development platform or PDP, ability to enter into additional license agreements and expectations regarding envafolimab ...